Public statement by the Global Commission on Drug Policy on ...
Apr 21, 2016 - does not call for an end to the criminalization and incarceration of drug users. ... It does not call on the World Health Organization (WHO) to revisit the scheduling system of drugs. It does not advocate for harm reduction and treatment strategies ... adopting progressive legislation and testing new approaches.
Public statement by the Global Commission on Drug Policy on UNGASS 2016 April 21, 2016 New York, New York
The Global Commission on Drug Policy is profoundly disappointed with the adopted outcome document agreed at the UN General Assembly Special Session (UNGASS) on "the world drug problem". The document does not acknowledge the comprehensive failure of the current drug control regime to reduce drug supply and demand. Nor does the outcome document account for the damaging effects of outdated policies on violence and corruption as well as on population health, human rights and wellbeing. By reaffirming that the three international conventions are the “cornerstone of global drug policy”, the document sustains an unacceptable and outdated legal status quo. UNGASS has not seriously addressed the critical flaws of international drug policy. It does not call for an end to the criminalization and incarceration of drug users. It does not urge states to abolish capital punishment for drug-related offences. It does not call on the World Health Organization (WHO) to revisit the scheduling system of drugs. It does not advocate for harm reduction and treatment strategies that have demonstrated effectiveness. Finally it does not offer proposals to regulate drugs and put governments – rather than criminals – in control. Equally important, the outcome document fails to recognize the considerable support for change demonstrated by many governments and civil society groups during UNGASS. It also excludes any mention of the many positive drug policy reforms already underway around the world. In fact many federal, state and city governments are adopting progressive legislation and testing new approaches. In order to achieve meaningful reforms to global drug policy the UN and member states must address the contradiction between the restrictions imposed by the international narcotics conventions and the necessity of governments and societies to regulate drugs. Several countries and some U.S. states are exploring regulation in a more humane and evidence-based manner. These approaches should be encouraged despite the restrictive language of the UN drug conventions. It is vital that the tensions between the letter of the conventions and ongoing initiatives on the ground are resolved. There will be another international opportunity to do so in 2019 when the UN Plan of Action that calls for a “drug free world” will be reviewed. The Global Commission urges governments and civil societies to continue moving forward and adopting drug policy reforms that are tailored to people’s needs and rights. We encourage and support them in their efforts to fundamentally realign drug policy so that health, citizen safety and human rights are paramount.
as far as possible, physical and mental health. From this ... of the mainstream and into marginalized subcultures where crime is rife. Once they ... directly related to the violation of the human rights of people who use drugs in many countries.
Mar 15, 2016 - At the Monetary Policy Meeting (MPM) held today, the Policy Board of the Bank of Japan ... Japan's economy has continued its moderate recovery trend, ... to Support Financial Institutions in Disaster Areas affected by the.
Mar 15, 2016 - Statement on Monetary Policy. 1. At the Monetary ... European debt problem and the momentum of economic activity and prices in Europe, and.
Nov 1, 2016 - The Bank will apply a negative interest rate of minus 0.1 percent to the ... Balances in current accounts held by financial institutions at the Bank.
Nov 1, 2017 - Enforcing the Mental Health Parity and Addiction Equity Act ..... pharmaceutical companies to develop non-addictive painkillers and ..... The Commission recommends that PDMP data integration with electronic health records,.
Nov 15, 2017 - on October 26, 2017, you acknowledged this crisis as one of epic proportion, impacting nearly ... enforcement, insurers, the medical industry, and researchers fight opioid abuse and misuse by reducing .... we will be failing our missio
Nov 15, 2017 - on October 26, 2017, you acknowledged this crisis as one of epic proportion, impacting nearly every community ...... The Joint Commission accredits and certifies health care organizations. Certification has implications for objective a
Jun 25, 2017 - a reliable source of healthcare coverage. ... 1) Maintain the Medicaid Program as an entitlement program supported by an open-ended ... rates to Medicare levels for evaluation and management billing codes for specialists.
Jun 25, 2017 - appropriate therapy.iv The current guidelines recommend initiating HIV treatment as soon as possible after infection, in order to stop replication of the virus, prevent irreparable harm to the immune system leading to progression to AI
Mar 20, 2006 - of the Peer Review Panel appointed to oversee the process. Thomas Hartung. Head of Unit. ECVAM. Institute for Health & Consumer Protection.
Sep 20, 2016 - the non-binding guidelines for reporting of non-financial information by .... impacts; management of non-financial risks; a company's .... 3 Non-Governmental organisations, trade unions, and consumer organisations. .... Companies shoul
Oct 14, 1983 - deceptive in specific cases include false oral or written representations, misleading price claims, sales of ... Second, we examine the practice from the perspective of a consumer acting reasonably in the ... Marketing and point-of-sal